Wednesday 29 January

Please note that this is the preliminary programme; times and titles are still subject to change.

08.30 - 08.45               Opening by Evelien Lemstra, chair EC ILBDC2025

08.45 - 09.15                 "The International DLB Consortium reaches thirty"
                                         Opening lecture by Ian McKeith (Newcastle UK)

09.15 - 10.15                   Plenaries

                                     I - Autonomic dysfunction in alphasynucleinopathies
                                       Alessandra Fanciulli (Innsbruck, Austria)

                                     II - Pathology of alphasynuclein disease 
                                        Amanda Woerman (Colorado, USA)

10.15 - 10.30               COFFEE BREAK

10.30 - 12.00                 Symposium I - Prodromal disease
                                       Chairs: Rosie Watson & Brad Boeve

Oral presentations:
Frédéric Blanc - Cognitive and Neuroimaging Outcome of Prodromal Dementia with Lewy Bodies
Michael Rigby - Clinical utility of skin biopsy for cutaneous phosphorylated alpha-synuclein in cognitive manifestations of Lewy body disease
Emma Somerville - Genome-wide association study of REM-sleep behaviour disorder identifies new risk locus.
Paula Loveland - The prodromal presentation of dementia with Lewy bodies: experience from an Australian longitudinal cohort study
Calum Hamilton - Core clinical features and depressive symptoms have different impacts on cognitive decline in MCI-LB
Brad Boeve - Preliminary Longitudinal Data on the Prodromal Synucleinopathy Rating Scale Among Patients with REM Sleep Behavior Disorder in the North American Prodromal Synucleinopathy (NAPS) Consortium

12.00 - 13.30               LUNCH/Poster sessions

13.30 - 15.00                  Symposium II - Pathology
                                        Chairs: Tiago Outeiro & Omar El Agnaf

Oral presentations:
Liisa Myllykangas - Accumulation of Lewy-related pathology starts in middle age and may be more common than previously thought - lessons from neuropathological population studies
Lauren Walker - Investigating the effect of mixed pathologies on neuropathological distribution in dementia with Lewy bodies
Patricia Diaz-Galvan - Substantia nigra iron deposition in Lewy Body disease: an imaging and neuropathology study
Na Zhao - Modeling Lewy Body Disease with SNCA Triplication iPSC-Derived Cortical Organoids and Identifying Therapeutic Drugs

15.00 - 15.30                BREAK

15.30 - 17.00                   Symposium III - Clinical features in DLB
                                        Chairs: Rimona Weil & Carla Abdelnour

Oral presentations:
Morgane Linard - Autonomic and neurosensory disorders in dementia with Lewy bodies patients: characteristics, follow-up and neural basis
Stuart McCarter - Core Clinical Features Associated with Survival in Dementia with Lewy Bodies (DLB)
Koij Kasanuki - Comparison of clinical and neuropathologic features in probable dementia with Lewy bodies with cognitive symptom onset before and after age 65
Gemma Bate - Developing a digital delirium framework for continuous monitoring of rest-activity and sleep in inpatients with Parkinson’s disease and Parkinson’s disease dementia.
João Durães - Circadian Rhythm disruption as a biomarker to differentiate between Dementia with Lewy Bodies and Alzheimer's Disease

18.00 - 20.00              Welcome reception